Back to Search
Start Over
The link between kidney disease and cancer: complications and treatment.
- Source :
-
Lancet (London, England) [Lancet] 2020 Jul 25; Vol. 396 (10246), pp. 277-287. - Publication Year :
- 2020
-
Abstract
- Acute and chronic kidney disease encompasses a complex set of diseases that can both lead to, and result from, cancer. In particular, kidney disease can arise from the use of chemotherapeutic agents. Many of the current and newly developed cancer chemotherapeutic agents are nephrotoxic and can promote kidney dysfunction, which frequently manifests during the terminal stages of cancer. Given the link between kidney disease and cancer development and treatment, the aim of this Review is to highlight the importance of multidisciplinary collaboration between oncologists and nephrologists to predict and prevent chemotherapeutic-induced nephrotoxicity. As new therapies are introduced to treat cancer, new renal toxicities require proper diagnosis and management. We anticipate that multidisciplinary collaborations will lead to the development and implementation of guidelines for clinicians to improve the therapeutic management of patients with both cancer and renal impairment.<br /> (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Subjects :
- Acute Kidney Injury chemically induced
Aged
Aged, 80 and over
Antineoplastic Agents therapeutic use
Humans
Interdisciplinary Communication
Kidney Diseases pathology
Nephrologists
Oncologists
Practice Guidelines as Topic
Predictive Value of Tests
Renal Insufficiency, Chronic epidemiology
Renal Insufficiency, Chronic physiopathology
Antineoplastic Agents adverse effects
Kidney Diseases chemically induced
Neoplasms drug therapy
Renal Insufficiency, Chronic complications
Subjects
Details
- Language :
- English
- ISSN :
- 1474-547X
- Volume :
- 396
- Issue :
- 10246
- Database :
- MEDLINE
- Journal :
- Lancet (London, England)
- Publication Type :
- Academic Journal
- Accession number :
- 32711803
- Full Text :
- https://doi.org/10.1016/S0140-6736(20)30540-7